Routine feasibility of postoperative chemoradiotherapy in head and neck squamous cell carcinoma at high risk of recurrence.
Sign Up to like & getrecommendations! Published in 2020 at "European annals of otorhinolaryngology, head and neck diseases"
DOI: 10.1016/j.anorl.2020.03.012
Abstract: OBJECTIVE To assess the feasibility in routine practice of postoperative chemoradiotherapy in head and neck squamous cell carcinoma (HNSCC) at high risk of recurrence. METHOD A single-center retrospective study recruited all patients receiving postoperative cisplatin… read more here.
Keywords: high risk; treatment; chemoradiotherapy; risk recurrence ... See more keywords
Comparison cisplatin with cisplatin plus 5FU in head and neck cancer patients received postoperative chemoradiotherapy.
Sign Up to like & getrecommendations! Published in 2017 at "Oral oncology"
DOI: 10.1016/j.oraloncology.2017.03.017
Abstract: PURPOSE To compare the treatment outcomes and toxicity of both cisplatin and cisplatin plus 5FU chemotherapy in head and neck cancer patients who have received surgery, in addition to postoperative chemoradiotherapy. MATERIALS AND METHODS From… read more here.
Keywords: cisplatin; plus 5fu; patients received; cisplatin plus ... See more keywords
Prognostic significance and postoperative chemoradiotherapy guiding value of mean platelet volume for locally advanced esophageal squamous cell carcinoma patients
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1094040
Abstract: Objective To investigate the predicting prognosis and guiding postoperative chemoradiotherapy (POCRT) value of preoperative mean platelet volume (MPV) in patients with locally advanced esophageal squamous cell carcinoma (LA-ESCC). Methods We proposed a blood biomarker, MPV,… read more here.
Keywords: locally advanced; mean platelet; advanced esophageal; postoperative chemoradiotherapy ... See more keywords